Advancing the management of latent tuberculosis infection and accelerating the goal of ending tuberculosis

doi:10.19983/j.issn.2096-8493.2024138

Abstract

CLC Number:

Xiao Wenjing, Shen Xin. Advancing the management of latent tuberculosis infection and accelerating the goal of ending tuberculosis[J]. Journal of Tuberculosis and Lung Disease , 2024, 5(5): 385-387. doi: 10.19983/j.issn.2096-8493.2024138

References 26

[1]	Hartman-Adams H, Clark K, Juckett G. Update on latent tuberculosis infection. Am Fam Physician, 2014, 89(11):889-896. pmid: 25077395
[2]	World Health Organization.Global tuberculosis report 2022. Geneva: World Health Organization, 2022.
[3]	全国结核病流行病学抽样调查技术指导组, 全国结核病流行病学抽样调查办公室. 2000年全国结核病流行病学抽样调查报告. 中国防痨杂志, 2002, 24(2): 65-108.
[4]	Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol, 1974, 99(2): 131-138. doi:10.1093/oxfordjournals.aje.a121593. pmid: 4810628
[5]	Vynnycky E, Fine PE. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect, 1997, 119(2): 183-201. doi:10.1017/s0950268897007917. pmid: 9363017
[6]	World Health Organization. Global tuberculosis report 2016. Geneva: World Health Organization, 2016.
[7]	World Health Organization. WHO calls for urgent action to end TB: Editors notes:About the UN High-level Meeting on TB The United Nations General Assembly High-level. Geneva: World Health Organization, 2018.
[8]	General Assembly of the United Nations. Political Declaration of the High—Level Meeting on the Fight against Tuberculosis:draft resolution/submitted by the President of the General Assembly. New York: General Assembly of the United Nations, 2023.
[9]	中华人民共和国国家卫生健康委员会, 中华人民共和国国家发展和改革委员会, 中华人民共和国教育部, 等. 关于印发遏制结核病行动计划 (2019—2022年) 的通知. 国卫疾控发〔2019〕4号. 2019-05-31.
[10]	中华人民共和国国家卫生健康委员会办公厅. 国家卫生健康委办公厅关于印发中国结核病预防控制工作技术规范(2020版)的通知. 国卫办疾控函〔2020〕279号. 2020-04-02.
[11]	中国防痨协会. T/CHATA 015—2021儿童结核分枝杆菌潜伏感染检测和预防性治疗. 2021-07-09.
[12]	中国防痨协会. T/CHATA 038—2024 结核分枝杆菌/人类免疫缺陷病毒双向筛查工作规范. 2024-07-05.
[13]	中国防痨协会. 高危人群结核分枝杆菌潜伏感染检测及预防性治疗专家共识. 中国防痨杂志, 2021, 43(9): 874-878. doi:10.3969/j.issn.1000-6621.2021.09.004.
[14]	中华医学会呼吸病学分会, 国家呼吸医学中心. 综合医疗机构结核病发病高危人群的预防性治疗专家共识. 中华结核和呼吸杂志, 2024, 47(10). doi:112147-20240328-00173.
[15]	高磊, 张慧, 胡茂桂, 等. 基于多中心调查数据和空间统计模型的全国结核分枝杆菌潜伏感染率估算. 中国防痨杂志, 2022, 44(1): 54-59. doi:10.19982/j.issn.1000-6621.20210661.
[16]	杨震, 雷囡, 赵飞, 等. 北京市昌平区高等院校新生结核分枝杆菌潜伏感染状况调查及潜伏感染者预防性治疗效果分析. 结核与肺部疾病杂志, 2022, 3(4): 274-280. doi:10.19983/j.issn.2096-8493.20220109.
[17]	谢欣, 唐利红, 黄晓霞, 等. 上海市某区菌阳肺结核患者密切接触者结核分枝杆菌潜伏感染及其相关因素. 中华结核和呼吸杂志, 2016, 39(12): 944-947. doi:10.3760/cma.j.issn.1001-0939.2016.12.008.
[18]	钟涛, 詹广兴, 范玉铮, 等. 深圳市南山区高危人群结核菌潜伏感染情况及影响因素. 中国热带医学, 2020, 20(8): 702-709, 716. doi:10.13604/j.cnki.46-1064/r.2020.08.03.
[19]	夏岚, 肖月, 陈闯, 等. 四川省2022年入学新生结核分枝杆菌潜伏感染与肺结核患病情况分析. 中国防痨杂志, 2024, 46(6): 664-671. doi:10.19982/j.issn.1000-6621.20240007.
[20]	谢周华, 韦柳迎, 董文逸, 等. HIV/AIDS合并结核分枝杆菌潜伏感染特征及影响因素分析. 中国热带医学, 2022, 22(8): 739-743. doi:10.13604/j.cnki.46-1064/r.2022.08.10.
[21]	Gao L, Lu W, Bai LQ, et al. Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study. Lancet Infect Dis, 2015, 15(3): 310-319. doi:10.1016/S1473-3099(14)71085-0. pmid: 25681063
[22]	徐彩红, 赵雁林. 全球加速扩展结核病预防性治疗行动计划背景下的中国对策. 中华结核和呼吸杂志, 2022, 45(3): 308-312. doi:10.3760/cma.j.cn112147-20210722-00520.
[23]	雷蓉蓉, 刘英, 张婷, 等. 重庆市结核病防治医务人员结核潜伏感染及预防性治疗的认知态度分析. 现代预防医学, 2020, 47(9): 1647-1650, 1669.
[24]	祖筱雯, 要玉霞, 龚德华, 等. 肺结核患者密切接触者对6个月单用异烟肼预防性治疗方案的接受度. 中国公共卫生, 2020, 36(3): 369-374. doi:10.11847/zgggws1127769.
[25]	赵丁源, 卢星星, 周丽平, 等. 异烟肼预防性治疗HIV/TB双重感染者效果观察. 公共卫生与预防医学, 2016, 27(2): 42-45.
[26]	任哲雯, 张国龙, 龚德华, 等. 结核潜伏感染者对12周预防性治疗方案的接受意愿研究. 中国防痨杂志, 2020, 42(5): 503-509. doi:10.3969/j.issn.1000-6621.2020.05.016.

Advancing the management of latent tuberculosis infection and accelerating the goal of ending tuberculosis

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 26

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Yang Shuqi, Li Feng. Advances in PD1/PD-L1 inhibitors in tuberculosis research [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 94-101.
[2]	Zhang Ying, Guo Chunhui. Research progress in the treatment of tuberculous tracheobronchial stenosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 87-93.
[3]	Yan Wenhua, Chen Wenjun. The value of digital health education in the preventive management of caregivers of patients with bacterial positive pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 73-78.
[4]	Gu Jinhua, Zhang Panpan. Evaluation of the application value of three detection methods for Mycobacterium tuberculosis in a comprehensive hospital [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 68-72.
[5]	Yan Qinghu, Xue Feng, Yu Yong, Qin Yi, Yan Qingmei, Cui Jia. The value of ultrasound-guided microwave ablation in the treatment of localized tuberculous lesions [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 55-60.
[6]	Qi Wei, Zhao Enyi. The epidemic characteristics and the trends of pulmonary tuberculosis in elderly and non-elderly in central urban area, Tianjin from 2006 to 2020 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 46-54.
[7]	Yang Yan, Dong Wen, Chen Jianjun, Zhang Yu. Epidemiologic characteristics of pulmonary tuberculosis in Zhuxi County, Shiyan City (2014-2023) [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 40-45.
[8]	Zheng Jianli, Wu Yumei, Zhang Shili, Du Zixian, Li Turong, Chen Shisheng, Lin Wenge. Cost-effectiveness analysis of active tuberculosis screening among high-risk populations in Longyan City, Fujian Province [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 35-39.
[9]	Zhao Yongnian, Zhang Lijie, Wang Tongmin. Analysis of the epidemiological characteristics of reported pulmonary tuberculosis in Xinjiang Production and Construction Corps, 2014—2023 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 30-34.
[10]	Wan Ying, Pang Xuewen, Zhang Fan. Evaluation on effect of health promotion for tuberculosis prevention and control in Tianjin City from 2010 to 2020 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 22-29.
[11]	Chen Yu, Li Xiaorui, Wang Miaoran, Zhang Yuqi, Liu Chang, Wang Zhaohua, Shi Jie, Fan Lichao, Yin Zhihua, Xie Jianping. The research progress on the role of metal ions in tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 102-112.
[12]	Chen Jing, Qin Yali, Wang Mingdong, Yang Rubin, Wang Qian, Peng Yanqing, Qiu Jiyao, Zhang Xiao, Zhou Xinai. The value of QuantiFERON-TB Gold Plus in the clinical diagnosis of active pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 61-67.
[13]	Liao Ying, Pang Yan, Zhao Jing, He Gaoqin, You Maolin, Wang Lei. Analysis on the reporting and case finding delay characteristics of pulmonary tuberculosis patients in Liangping District, Chongqing from 2018 to 2023 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 8-13.
[14]	. [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 495-499.
[15]	Hu Xinyang, Gao Jingtao. Interpretation of WHO global tuberculosis report 2024 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 500-504.